PROACTIVE CELIAC STUDY:
The goal of this phase 2 clinical trial is to test the safety and effects of the investigational medication PRV-015.
In combination with a gluten-free diet, PRV-015 aims to reduce symptoms and intestinal inflammation caused by accidental gluten exposure.
- 18-70 years old
- Biopsy-confirmed celiac disease
- On a gluten-free diet for at least the last 12 months
- Still experiencing celiac disease symptoms